Pentraxin-3 as a poor marker of fibrosis in metabolic dysfunction-associated steatotic liver disease among older adults: findings from the PolSenior2 substudy
Our study suggests that plasma PTX-3 levels are not sensitive enough to be used as a non-specific marker of liver fibrosis in older adults.
Authors
- Aleksander Jerzy Owczarek (ORCID: https://orcid.org/0000-0003-1179-6932)
- Joanna Musialik (ORCID: https://orcid.org/0000-0002-6146-3805)
- Małgorzata Mossakowska (ORCID: https://orcid.org/0000-0002-9340-3188)
- Jerzy Chudek (ORCID: https://orcid.org/0000-0002-6367-7794)
- Magdalena Olszanecka‐Glinianowicz (ORCID: https://orcid.org/0000-0001-5632-5590)
- Adrian Stefański (ORCID: https://orcid.org/0000-0002-7019-1928)
- Andrzej Więcek
- Katarzyna Zięba (ORCID: https://orcid.org/0009-0002-3053-5340)
Institutions
- Medical University of Silesia (PL)
- International Institute of Molecular and Cell Biology (PL)
- Gdańsk Medical University (PL)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-02-24
- DOI
- https://doi.org/10.3389/fmed.2025.1445973
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00